![S5F S5F](https://data.pdbj.org/pdbjplus/data/cc/svg/S5F.svg) | S5F | 表記: | 6-chloro-4-{(8S)-8-[(4H-1,2,4-triazol-4-yl)methyl]-6-azaspiro[3.4]octan-6-yl}pyrimidin-2(1H)-one | 組成式: | C14 H17 Cl N6 O | SMILES: | ClC1=CC(=NC(=O)N1)N1CC(Cn2cnnc2)C2(CCC2)C1 | InChi: | InChI=1S/C14H17ClN6O/c15-11-4-12(19-13(22)18-11)21-6-10(5-20-8-16-17-9-20)14(7-21)2-1-3-14/h4,8-10H,1-3,5-7H2,(H,18,19,22)/t10-/m0/s1 | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 6-chloro-4-{(8S)-8-[(4H-1,2,4-triazol-4-yl)methyl]-6-azaspiro[3.4]octan-6-yl}pyrimidin-2(1H)-one |
|
![S5O S5O](https://data.pdbj.org/pdbjplus/data/cc/svg/S5O.svg) | S5O | 表記: | (1R,5S,6R)-3-(7H-purin-6-yl)-3-azabicyclo[3.2.2]nonane-6-carboxylic acid | 組成式: | C14 H17 N5 O2 | SMILES: | O=C(O)C1CC2CCC1CN(C2)c1ncnc2nc[NH]c21 | InChi: | InChI=1S/C14H17N5O2/c20-14(21)10-3-8-1-2-9(10)5-19(4-8)13-11-12(16-6-15-11)17-7-18-13/h6-10H,1-5H2,(H,20,21)(H,15,16,17,18)/t8-,9-,10-/m1/s1 | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | (1R,5S,6R)-3-(7H-purin-6-yl)-3-azabicyclo[3.2.2]nonane-6-carboxylic acid |
|
![WVG WVG](https://data.pdbj.org/pdbjplus/data/cc/svg/WVG.svg) | WVG | 表記: | 3-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]propanoic acid | 組成式: | C14 H18 N4 O2 | SMILES: | c21c(ncc1)ncnc2N3CCCC(CCC(O)=O)C3 | InChi: | InChI=1S/C14H18N4O2/c19-12(20)4-3-10-2-1-7-18(8-10)14-11-5-6-15-13(11)16-9-17-14/h5-6,9-10H,1-4,7-8H2,(H,19,20)(H,15,16,17)/t10-/m1/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 3-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]propanoic acid |
|
![WVM WVM](https://data.pdbj.org/pdbjplus/data/cc/svg/WVM.svg) | WVM | 表記: | (8S)-8-fluoro-6-(6-{[(2R)-2-hydroxypropyl]amino}pyrimidin-4-yl)-6-azaspiro[3.4]octane-8-carboxylic acid | 組成式: | C15 H21 F N4 O3 | SMILES: | c3nc(NCC(C)O)cc(N2CC1(CCC1)C(C2)(C(O)=O)F)n3 | InChi: | InChI=1S/C15H21FN4O3/c1-10(21)6-17-11-5-12(19-9-18-11)20-7-14(3-2-4-14)15(16,8-20)13(22)23/h5,9-10,21H,2-4,6-8H2,1H3,(H,22,23)(H,17,18,19)/t10-,15+/m1/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | (8S)-8-fluoro-6-(6-{[(2R)-2-hydroxypropyl]amino}pyrimidin-4-yl)-6-azaspiro[3.4]octane-8-carboxylic acid |
|
![S5U S5U](https://data.pdbj.org/pdbjplus/data/cc/svg/S5U.svg) | S5U | 表記: | 4-[methyl(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]butanoic acid | 組成式: | C12 H14 N4 O3 | SMILES: | O=C(O)CCCN(C)C(=O)c1ncnc2[NH]ccc12 | InChi: | InChI=1S/C12H14N4O3/c1-16(6-2-3-9(17)18)12(19)10-8-4-5-13-11(8)15-7-14-10/h4-5,7H,2-3,6H2,1H3,(H,17,18)(H,13,14,15) | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 4-[methyl(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)amino]butanoic acid |
|
![WVY WVY](https://data.pdbj.org/pdbjplus/data/cc/svg/WVY.svg) | WVY | 表記: | [(3S)-2-oxopiperidin-3-yl]methyl [4-(1H-pyrazol-1-yl)phenyl]acetate | 組成式: | C17 H19 N3 O3 | SMILES: | c3nn(c2ccc(CC(OCC1C(NCCC1)=O)=O)cc2)cc3 | InChi: | InChI=1S/C17H19N3O3/c21-16(23-12-14-3-1-8-18-17(14)22)11-13-4-6-15(7-5-13)20-10-2-9-19-20/h2,4-7,9-10,14H,1,3,8,11-12H2,(H,18,22)/t14-/m0/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | [(3S)-2-oxopiperidin-3-yl]methyl [4-(1H-pyrazol-1-yl)phenyl]acetate |
|
![S63 S63](https://data.pdbj.org/pdbjplus/data/cc/svg/S63.svg) | S63 | 表記: | (3R)-1-[(4-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)acetyl]-3-methylpyrrolidine-3-carboxylic acid | 組成式: | C15 H16 Cl N3 O3 | SMILES: | CC1(CCN(C1)C(=O)Cc1c[NH]c2nccc(Cl)c21)C(=O)O | InChi: | InChI=1S/C15H16ClN3O3/c1-15(14(21)22)3-5-19(8-15)11(20)6-9-7-18-13-12(9)10(16)2-4-17-13/h2,4,7H,3,5-6,8H2,1H3,(H,17,18)(H,21,22)/t15-/m1/s1 | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | (3R)-1-[(4-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)acetyl]-3-methylpyrrolidine-3-carboxylic acid |
|
![WW1 WW1](https://data.pdbj.org/pdbjplus/data/cc/svg/WW1.svg) | WW1 | 表記: | 3-{[(2R)-2-phenylpropyl]sulfanyl}-7H-[1,2,4]triazolo[4,3-b][1,2,4]triazole | 組成式: | C12 H13 N5 S | SMILES: | c3nc1n(c(nn1)SCC(c2ccccc2)C)n3 | InChi: | InChI=1S/C12H13N5S/c1-9(10-5-3-2-4-6-10)7-18-12-16-15-11-13-8-14-17(11)12/h2-6,8-9H,7H2,1H3,(H,13,14,15)/t9-/m0/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 3-{[(2R)-2-phenylpropyl]sulfanyl}-7H-[1,2,4]triazolo[4,3-b][1,2,4]triazole |
|
![WW4 WW4](https://data.pdbj.org/pdbjplus/data/cc/svg/WW4.svg) | WW4 | 表記: | 4-{(3R)-3-[(1,3-thiazol-2-yl)methyl]pyrrolidin-1-yl}-7H-pyrrolo[2,3-d]pyrimidine | 組成式: | C14 H15 N5 S | SMILES: | n1ccc2c1ncnc2N4CCC(Cc3nccs3)C4 | InChi: | InChI=1S/C14H15N5S/c1-3-16-13-11(1)14(18-9-17-13)19-5-2-10(8-19)7-12-15-4-6-20-12/h1,3-4,6,9-10H,2,5,7-8H2,(H,16,17,18)/t10-/m1/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 4-{(3R)-3-[(1,3-thiazol-2-yl)methyl]pyrrolidin-1-yl}-7H-pyrrolo[2,3-d]pyrimidine |
|
![S6C S6C](https://data.pdbj.org/pdbjplus/data/cc/svg/S6C.svg) | S6C | 表記: | [(3S)-1-(7H-purin-6-yl)piperidin-3-yl]acetic acid | 組成式: | C12 H15 N5 O2 | SMILES: | O=C(O)CC1CCCN(C1)c1ncnc2nc[NH]c12 | InChi: | InChI=1S/C12H15N5O2/c18-9(19)4-8-2-1-3-17(5-8)12-10-11(14-6-13-10)15-7-16-12/h6-8H,1-5H2,(H,18,19)(H,13,14,15,16)/t8-/m0/s1 | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | [(3S)-1-(7H-purin-6-yl)piperidin-3-yl]acetic acid |
|
![WWJ WWJ](https://data.pdbj.org/pdbjplus/data/cc/svg/WWJ.svg) | WWJ | 表記: | 5-ethyl-4-{(3R)-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}-7H-pyrrolo[2,3-d]pyrimidine | 組成式: | C17 H22 N6 O | SMILES: | c1(ncnc2c1c(CC)cn2)N3CCCC(C3)Cc4nc(C)no4 | InChi: | InChI=1S/C17H22N6O/c1-3-13-8-18-16-15(13)17(20-10-19-16)23-6-4-5-12(9-23)7-14-21-11(2)22-24-14/h8,10,12H,3-7,9H2,1-2H3,(H,18,19,20)/t12-/m1/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 5-ethyl-4-{(3R)-3-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]piperidin-1-yl}-7H-pyrrolo[2,3-d]pyrimidine |
|
![S6N S6N](https://data.pdbj.org/pdbjplus/data/cc/svg/S6N.svg) | S6N | 表記: | (3S)-6,6-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)piperidine-3-carboxylic acid | 組成式: | C15 H18 N4 O3 | SMILES: | O=C(c1ncnc2[NH]ccc21)N1CC(CCC1(C)C)C(=O)O | InChi: | InChI=1S/C15H18N4O3/c1-15(2)5-3-9(14(21)22)7-19(15)13(20)11-10-4-6-16-12(10)18-8-17-11/h4,6,8-9H,3,5,7H2,1-2H3,(H,21,22)(H,16,17,18)/t9-/m0/s1 | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | (3S)-6,6-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)piperidine-3-carboxylic acid |
|
![WWS WWS](https://data.pdbj.org/pdbjplus/data/cc/svg/WWS.svg) | WWS | 表記: | 3-[(5-chloropyridin-2-yl)methyl]-3H-purin-6-amine | 組成式: | C11 H9 Cl N6 | SMILES: | c1(ncc(cc1)Cl)CN3C=NC(=C2N=CN=C23)N | InChi: | InChI=1S/C11H9ClN6/c12-7-1-2-8(14-3-7)4-18-6-17-10(13)9-11(18)16-5-15-9/h1-3,5-6H,4,13H2 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 3-[(5-chloropyridin-2-yl)methyl]-3H-purin-6-amine |
|
![S6U S6U](https://data.pdbj.org/pdbjplus/data/cc/svg/S6U.svg) | S6U | 表記: | 2-(2-oxo-1,3-oxazolidin-3-yl)ethyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate | 組成式: | C12 H12 N4 O4 | SMILES: | O=C1OCCN1CCOC(=O)c1ncnc2[NH]ccc21 | InChi: | InChI=1S/C12H12N4O4/c17-11(19-5-3-16-4-6-20-12(16)18)9-8-1-2-13-10(8)15-7-14-9/h1-2,7H,3-6H2,(H,13,14,15) | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 2-(2-oxo-1,3-oxazolidin-3-yl)ethyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate |
|
![WX4 WX4](https://data.pdbj.org/pdbjplus/data/cc/svg/WX4.svg) | WX4 | 表記: | {1-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1H-1,2,3-triazol-4-yl}methanol | 組成式: | C14 H17 N7 O | SMILES: | C3CN(c2c1ccnc1ncn2)CC(C3)n4cc(CO)nn4 | InChi: | InChI=1S/C14H17N7O/c22-8-10-6-21(19-18-10)11-2-1-5-20(7-11)14-12-3-4-15-13(12)16-9-17-14/h3-4,6,9,11,22H,1-2,5,7-8H2,(H,15,16,17)/t11-/m1/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | {1-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1H-1,2,3-triazol-4-yl}methanol |
|
![WX7 WX7](https://data.pdbj.org/pdbjplus/data/cc/svg/WX7.svg) | WX7 | 表記: | 5-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1,3,4-oxadiazol-2(3H)-one | 組成式: | C13 H14 N6 O2 | SMILES: | C4N(c2c1c(ncc1)ncn2)CC(C3=NNC(O3)=O)CC4 | InChi: | InChI=1S/C13H14N6O2/c20-13-18-17-12(21-13)8-2-1-5-19(6-8)11-9-3-4-14-10(9)15-7-16-11/h3-4,7-8H,1-2,5-6H2,(H,18,20)(H,14,15,16)/t8-/m1/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 5-[(3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl]-1,3,4-oxadiazol-2(3H)-one |
|
![WXA WXA](https://data.pdbj.org/pdbjplus/data/cc/svg/WXA.svg) | WXA | 表記: | 5-ethyl-4-[(3R)-3-(methylsulfonyl)piperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine | 組成式: | C14 H20 N4 O2 S | SMILES: | C1CCC(CN1c3c2c(CC)cnc2ncn3)S(C)(=O)=O | InChi: | InChI=1S/C14H20N4O2S/c1-3-10-7-15-13-12(10)14(17-9-16-13)18-6-4-5-11(8-18)21(2,19)20/h7,9,11H,3-6,8H2,1-2H3,(H,15,16,17)/t11-/m1/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 5-ethyl-4-[(3R)-3-(methylsulfonyl)piperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine |
|
![WXD WXD](https://data.pdbj.org/pdbjplus/data/cc/svg/WXD.svg) | WXD | 表記: | 5-ethyl-4-[(3S)-3-(methylsulfonyl)piperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine | 組成式: | C14 H20 N4 O2 S | SMILES: | c3(N1CCCC(C1)S(C)(=O)=O)c2c(CC)cnc2ncn3 | InChi: | InChI=1S/C14H20N4O2S/c1-3-10-7-15-13-12(10)14(17-9-16-13)18-6-4-5-11(8-18)21(2,19)20/h7,9,11H,3-6,8H2,1-2H3,(H,15,16,17)/t11-/m0/s1 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 5-ethyl-4-[(3S)-3-(methylsulfonyl)piperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine |
|
![WXG WXG](https://data.pdbj.org/pdbjplus/data/cc/svg/WXG.svg) | WXG | 表記: | 1-{2-[(9H-purin-6-yl)sulfanyl]ethyl}pyrrolidin-2-one | 組成式: | C11 H13 N5 O S | SMILES: | c1(ncnc2ncnc12)SCCN3C(=O)CCC3 | InChi: | InChI=1S/C11H13N5OS/c17-8-2-1-3-16(8)4-5-18-11-9-10(13-6-12-9)14-7-15-11/h6-7H,1-5H2,(H,12,13,14,15) | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 1-{2-[(9H-purin-6-yl)sulfanyl]ethyl}pyrrolidin-2-one |
|
![WXJ WXJ](https://data.pdbj.org/pdbjplus/data/cc/svg/WXJ.svg) | WXJ | 表記: | 4-[2-(6-amino-3H-purin-3-yl)ethoxy]benzonitrile | 組成式: | C14 H12 N6 O | SMILES: | c3c(OCCN1C=2C(=C(N)N=C1)N=CN=2)ccc(c3)C#N | InChi: | InChI=1S/C14H12N6O/c15-7-10-1-3-11(4-2-10)21-6-5-20-9-19-13(16)12-14(20)18-8-17-12/h1-4,8-9H,5-6,16H2 | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 4-[2-(6-amino-3H-purin-3-yl)ethoxy]benzonitrile |
|
![S7F S7F](https://data.pdbj.org/pdbjplus/data/cc/svg/S7F.svg) | S7F | 表記: | (3S)-1-(6-amino-5-methylpyridine-3-sulfonyl)piperidine-3-carboxamide | 組成式: | C12 H18 N4 O3 S | SMILES: | O=S(=O)(c1cc(C)c(N)nc1)N1CCCC(C1)C(N)=O | InChi: | InChI=1S/C12H18N4O3S/c1-8-5-10(6-15-11(8)13)20(18,19)16-4-2-3-9(7-16)12(14)17/h5-6,9H,2-4,7H2,1H3,(H2,13,15)(H2,14,17)/t9-/m0/s1 | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | (3S)-1-(6-amino-5-methylpyridine-3-sulfonyl)piperidine-3-carboxamide |
|
![WXS WXS](https://data.pdbj.org/pdbjplus/data/cc/svg/WXS.svg) | WXS | 表記: | 4-methyl-5-{[(9H-purin-6-yl)sulfanyl]methyl}-2H-1,3-dioxol-2-one | 組成式: | C10 H8 N4 O3 S | SMILES: | c2(c1c(ncn1)ncn2)SCC3=C(C)OC(=O)O3 | InChi: | InChI=1S/C10H8N4O3S/c1-5-6(17-10(15)16-5)2-18-9-7-8(12-3-11-7)13-4-14-9/h3-4H,2H2,1H3,(H,11,12,13,14) | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 4-methyl-5-{[(9H-purin-6-yl)sulfanyl]methyl}-2H-1,3-dioxol-2-one |
|
![S7O S7O](https://data.pdbj.org/pdbjplus/data/cc/svg/S7O.svg) | S7O | 表記: | 2-[methyl-[(9-oxidanylidene-1$l^{4},7,8-triazabicyclo[4.3.0]nona-1(6),2,4-trien-3-yl)carbonyl]amino]ethanoic acid | 組成式: | C10 H11 N4 O4 | SMILES: | O=C(O)CN(C)C(=O)c1c[n+]2C(=O)NNc2cc1 | InChi: | InChI=1S/C10H10N4O4/c1-13(5-8(15)16)9(17)6-2-3-7-11-12-10(18)14(7)4-6/h2-4H,5H2,1H3,(H2,12,15,16,18)/p+1 | 定義日: | 2022-06-23 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | N-methyl-N-(3-oxo-2,3-dihydro-1H-[1,2,4]triazolo[4,3-a]pyridin-4-ium-6-carbonyl)glycine |
|
![WXY WXY](https://data.pdbj.org/pdbjplus/data/cc/svg/WXY.svg) | WXY | 表記: | (1-azaspiro[4.5]decan-1-yl)(7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanone | 組成式: | C16 H20 N4 O | SMILES: | C4CCC3(CCCN3C(c2c1c(ncc1)ncn2)=O)CC4 | InChi: | InChI=1S/C16H20N4O/c21-15(13-12-5-9-17-14(12)19-11-18-13)20-10-4-8-16(20)6-2-1-3-7-16/h5,9,11H,1-4,6-8,10H2,(H,17,18,19) | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | (1-azaspiro[4.5]decan-1-yl)(7H-pyrrolo[2,3-d]pyrimidin-4-yl)methanone |
|
![WYA WYA](https://data.pdbj.org/pdbjplus/data/cc/svg/WYA.svg) | WYA | 表記: | 3-{[methyl(pyrido[2,3-b]pyrazin-6-yl)amino]methyl}[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one | 組成式: | C14 H12 N8 O | SMILES: | c3c(N(C)Cc1n2c(nn1)C(=O)NC=C2)nc4c(c3)nccn4 | InChi: | InChI=1S/C14H12N8O/c1-21(10-3-2-9-12(18-10)16-5-4-15-9)8-11-19-20-13-14(23)17-6-7-22(11)13/h2-7H,8H2,1H3,(H,17,23) | 定義日: | 2020-11-17 | 最終更新日: | 2022-07-08 | 公開日: | 2022-07-13 | 識別子(ID): | 3-{[methyl(pyrido[2,3-b]pyrazin-6-yl)amino]methyl}[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one |
|